Global Colorectal Cancer Therapeutics Market Size To Worth USD 19.90 Billion By 2033 | CAGR of 4.59%

Global Colorectal Cancer Therapeutics Market Size To Worth USD 19.90 Billion by 2033

According to a research report published by Spherical Insights & Consulting, The Global Colorectal Cancer Therapeutics Market Size is to Grow from USD 12.71 Billion in 2023 to USD 19.90 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 4.59% during the projected period.

Browse key industry insights spread across 220 pages with 100 Market data tables and figures & charts from the report on The Global Colorectal Cancer Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, and Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033 Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/colorectal-cancer-therapeutics-market

Colorectal cancer is a form of tumor that develops in the rectum or colon (the large intestine). It is one of the most common types of cancer worldwide. Colorectal cancer is the second deadliest tumor kind and the third most common. Mutations in cancer driver genes result in unregulated cell growth, which is the disease's etiology. It could result in fatalities or severe injuries. People are inclined to develop colorectal cancer as they age. Most incidents involve adults over the age of fifty. Diarrhea, constipation, blood in the stool, stomach pain, unexpected weight loss, exhaustion, and an iron deficiency are common symptoms. Many patients will not show any symptoms early in their condition. Regular screening is vital for early detection. Cancer is one of the main causes of death in the world, killing over 10 million people each year. Scientists are applying precision oncology, artificial intelligence, DNA sequencing, and other technologies to advance cancer diagnosis and therapy. Growing education initiatives and screening programs have led to earlier detection and diagnosis of colorectal cancer. Early diagnosis enables earlier intervention and therapy, resulting in better patient results. Furthermore, improving patient outcomes and maintaining long-term efficacy are demanding challenges, and when medication resistance develops, it harms the colorectal cancer treatment market.

The targeted therapy segment holds the largest market share of the colorectal cancer therapeutics market during the projected timeframe.   

Based on the therapy, the colorectal cancer therapeutics market is divided into targeted therapy, immunotherapy, chemotherapy, and others. Among these, the targeted therapy segment holds the largest market share of the colorectal cancer therapeutics market during the projected timeframe. Targeted therapy is a revolutionary approach that has significantly boosted overall survival in colorectal cancer therapy patients. This is mostly due to their reputation as successful and sophisticated treatments and even the critical life-saving features that targeted therapy delivers.   

The colorectal adenocarcinoma segment is anticipated to grow at the highest CAGR of the colorectal cancer therapeutics market during the projected timeframe.   

Based on the cancer type, the colorectal cancer therapeutics market is divided into colorectal adenocarcinoma, gastrointestinal carcinoid tumors, and others. Among these, the colorectal adenocarcinoma segment is anticipated to grow at the highest CAGR of the colorectal cancer therapeutics market during the projected timeframe. This is mostly because a sizeable fraction of colorectal cancer cases generally are caused by colorectal adenocarcinoma. The high market value of colorectal adenocarcinoma in terms of treatment and the occurrence of a rarer version of the disease that requires aggressive therapy are additional reasons propelling the expansion of this market.

The hospital pharmacies segment is expected to grow at a significant pace in the colorectal cancer therapeutics market during the projected timeframe.   

Based on the distribution channel, the colorectal cancer therapeutics market is divided into hospital pharmacies, retail pharmacies, online pharmacies, and others. Among these, the hospital pharmacies segment is expected to grow at a significant pace in the colorectal cancer therapeutics market during the projected timeframe. Hospital pharmacies provide medications to patients undergoing inpatient or outpatient care in hospital settings. This is because medications are typically supplied in conjunction with a thorough diagnosis, which is prevalent at these institutions. Furthermore, the medications can only be given intravenously by experienced medical experts in certain areas.   

North America is expected to hold the largest share of the colorectal cancer therapeutics market over the forecast period.

North America is expected to hold the largest share of the colorectal cancer therapeutics market over the forecast period. North America accounts for the majority of the researched market, owing to the increased incidence of colorectal cancer in the United States and many initiatives. According to the American Cancer Society, colorectal cancer is one of the most common cancers diagnosed in men and women in the United States, with an estimated 104,270 new every year, 45,230 new cases of rectal cancer are discovered. Colorectal cancer (CRC) remains the leading cause of cancer-related death in the United States, along with early cancer-related death in Canada, according to reports in 2021.

Asia Pacific is predicted to grow at the fastest pace in the colorectal cancer therapeutics market during the projected timeframe. This is due to the expanding elderly population and increased participation in colorectal cancer awareness programs by both public and commercial entities. For example, according to research published in the National Library of Medicine in April 2022, several trials population-based CRC screening programs have been implemented in some Chinese administrative divisions, which can help with the early detection and treatment of these disorders. Colorectal cancer awareness is increasing as disposable incomes rise throughout the region. The rising frequency of colorectal cancer in the region's major countries, together with the rising status of colorectal disorders as the leading cause of death, is probably driving regional colorectal cancer drug market growth.

The market is predicted to grow rapidly in Europe due to the huge number of people suffering from colorectal cancer. High-growth nations such as the United Kingdom, France, and Spain will help to expand the European market.

Due to the increasing prevalence and awareness of colorectal cancer, it is projected that the Latin American market for this disease will grow significantly. In comparison to other regions, the Middle East and Africa are expected to grow slower in the short term but more rapidly in the long run.

Major vendors in the colorectal cancer therapeutics market are Bayer AG, Bristol Myers Squibb, Eli Lilly and Company, Genentech, Inc., Ipsen Biopharmaceuticals, Inc., Merck Sharp & Dohme Corp., Pfizer Inc., Regeneron Pharmaceuticals, Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Taiho Pharmaceutical, Novartis AG, Amgen Inc., Johnson & Johnson, and others.

 Recent Developments

• In January 2023, HUTCHMED approved Takeda a license to develop and market Fruquintinib outside China. This strategic strategy assisted the business in expanding its geographic reach and revenue.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the colorectal cancer therapeutics market based on the below-mentioned segments: 

Global Colorectal Cancer Therapeutics Market, By Therapy

• Targeted Therapy
• Immunotherapy
• Chemotherapy
• Others

Global Colorectal Cancer Therapeutics Market, By Cancer Type

• Colorectal Adenocarcinoma
• Gastrointestinal Carcinoid Tumors
• Others

Global Colorectal Cancer Therapeutics Market, By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Colorectal Cancer Therapeutics Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa  

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter